APA (7th ed.) Citation

A, L. G., S, P., A, B., M, P., E, B., R, A., . . . A, A. (2024). Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis. Minerva medica, 115(4), 430. https://doi.org/10.23736/S0026-4806.24.09409-6

Chicago Style (17th ed.) Citation

A, Lo Gullo, et al. "Multicenter Observational Study on the Efficacy of Selective Janus Kinase-1 Inhibitor Upatacitinib in Rheumatoid Arthritis." Minerva Medica 115, no. 4 (2024): 430. https://doi.org/10.23736/S0026-4806.24.09409-6.

MLA (9th ed.) Citation

A, Lo Gullo, et al. "Multicenter Observational Study on the Efficacy of Selective Janus Kinase-1 Inhibitor Upatacitinib in Rheumatoid Arthritis." Minerva Medica, vol. 115, no. 4, 2024, p. 430, https://doi.org/10.23736/S0026-4806.24.09409-6.